Abstract | OBJECTIVE: STUDY DESIGN: RESULTS: CONCLUSION: All regimens alleviated climacteric symptoms and provided excellent bleeding control, even during the early weeks of treatment. A choice of various dose combinations offers flexibility of dosing, thus enabling therapy to be tailored to the needs of individual women.
|
Authors | J E Heikkinen, R T Vaheri, S M Ahomäki, P M Kainulainen, A T Viitanen, U M Timonen |
Journal | American journal of obstetrics and gynecology
(Am J Obstet Gynecol)
Vol. 182
Issue 3
Pg. 560-7
(Mar 2000)
ISSN: 0002-9378 [Print] United States |
PMID | 10739508
(Publication Type: Clinical Trial, Clinical Trial, Phase II, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Drug Combinations
- Lipids
- Progesterone Congeners
- Estradiol
- Medroxyprogesterone Acetate
|
Topics |
- Bone Density
(drug effects)
- Climacteric
(drug effects)
- Double-Blind Method
- Drug Administration Schedule
- Drug Combinations
- Endometrium
(drug effects)
- Estradiol
(analogs & derivatives, therapeutic use)
- Female
- Hemorrhage
(prevention & control)
- Hormone Replacement Therapy
- Humans
- Lipids
(blood)
- Medroxyprogesterone Acetate
(therapeutic use)
- Middle Aged
- Postmenopause
(blood, drug effects, physiology)
- Progesterone Congeners
(therapeutic use)
|